Palbociclib

Palbociclib (PD-0332991) is an orally available pyridopyrimidine-derived cyclin-dependent kinase (CDK) inhibitor with potential antineoplastic activity.

Specifictaions: Moligand™, ≥99%

MDL Number: C24H29N7O2

Molecular Formula: 447.53

Molecular Weight: 810-186-2

PubChem CID: 5330286

Isomeric SMILES: CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C

Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/P126849-SCI_3522795715c438474a8fe6ab5028384e.pdf

UPC:

51112021

Condition:

New

Weight:

1.09 Ounces

HazmatClass:

No

Quantity:

1

Unit of Measurement:

EA

WeightUOM:

LB

MPN:

P126849-1g

CAS:

571190-30-2

Product Size:

1g

Health Hazards:

Carcinogen,Toxic

Hazard Statement Codes:

H361;H360;H372;H302;H411;H373;H341;H301

Precautionary Statement Codes:

P319;P318;P301+P317;P301+P316;P203;P330;P391;P270;P281;P260;P264;P501;P405;P321;P280;P273